Hereditary Haemorrhagic Telangiectasia Clinical Trials

25 clinical trials for Hereditary Haemorrhagic Telangiectasia across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Registry for Patients with Vascular Malformations and Tumors (VasMuT) — RECRUITING
• Conjunctival and chorioretinal vascular alterations in Osler’s disease — RECRUITING
• Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device — RECRUITING · NA
• Immunological Effects of Iron Supplementation in HHT Disease — RECRUITING · NA
• A PHASE 1/2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 2-PART STUDY OF THE SAFETY, TOLERABILITY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE DOSE ALN-6400 IN ADULT HEALTHY VOLUNTEERS AND MULTIPLE DOSE ALN-6400 IN ADULT PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) — RECRUITING · PHASE1
• DOXYCYCLINE CROSSOVER TRIAL FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) — RECRUITING
• A PHASE 1/2, FIRST-IN-HUMAN, MULTICENTER, ASCENDING SINGLE-DOSE AND MULTI-DOSE STUDY TO ASSESS THE SAFETY OF DIAG723, A NOVEL BISPECIFIC ALK-1 AND BMPRII AGONIST ANTIBODY IN ADULT PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA (DIAMOND TRIAL) — NOT_YET_RECRUITING · PHASE1
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ENGASERTIB IN SUBJECTS WITH MODERATE TO SEVERE HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) — NOT_YET_RECRUITING · PHASE3
• Quality of Life in Pediatric Participants With HHT — NOT_YET_RECRUITING
• Phase II randomized study on efficacy of nintedanib for treatment of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients - EPISTOP — TERMINATED · PHASE2
• Genotype Expression and Phenotype of Endothelial Cells, Carrying an ACVRL1, ENG or SMAD4 Mutation, in Response to BMP9 for the Identification of New Therapeutic Targets in Hereditary Haemorrhagic Telangiectasia — COMPLETED · NA
• Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHT — ACTIVE_NOT_RECRUITING
• Hereditary Haemorrhagic Telangiectasia Flight Safety Study — COMPLETED
• Diet and Hereditary Haemorrhagic Telangiectasia — COMPLETED · NA
• Iron Deficiency and Hereditary Haemorrhagic Telangiectasia — TERMINATED · NA
• Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) — OTHER
• A RANDOMISED, PLACEBO CONTROLLED, DOUBLE BLIND, MULTICENTRE PROOF OF CONCEPT STUDY TO ASSESS THE SAFETY AND EFFICACY OF TWO DOSES OF VAD044 IN PATIENTS WITH HEREDITARY HAEMORRHAGIC TELANGIECTASIA (HHT) — NOT_YET_RECRUITING
• Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia — COMPLETED
• LOW-DOSE SIROLIMUS FOR NOSEBLEEDS IN HHT: A PHASE II PILOT STUDY — NOT_YET_RECRUITING · PHASE2
• Immunmodulation in Patients With HHT — COMPLETED
• TACROLIMUS CROSSOVER TRIAL FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) — NOT_YET_RECRUITING
• Vitamin D and Hereditary Haemorrhagic Telangiectasia — OTHER · PHASE2
• Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation — COMPLETED
• Pulmonary Arteriovenous Malformations (PAVMs) in Hereditary Haemorrhagic Telangiectasia (HHT) — COMPLETED
• A PHASE II STUDY TO EVALUATE THE EFFECTS OF UP TO 12 WEEKS OF PAZOPANIB DOSING ON BLEEDING IN SUBJECTS WITH HEREDITARY HAEMORRHAGIC TELANGIECTASIA. — COMPLETED · PHASE2

Refine this search